This inventor holds 1 USPTO granted patent. Top assignees: Prestige Biopharma Idc Co., Ltd., Prestige Biopharma Pte. Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: So Yeon Park: Innovator in Biopharmaceuticals
Introduction
So Yeon Park is a prominent inventor based in Singapore, known for her contributions to the field of biopharmaceuticals. She has made significant strides in developing innovative solutions that address critical health challenges. Her work has garnered attention in the scientific community, particularly for her unique approach to antibody development.
Latest Patents
So Yeon Park holds a patent for a "Novel CTHRC1-Specific Antibody and Use Thereof." This patent represents a significant advancement in the understanding and application of antibodies in therapeutic settings. With 1 patent to her name, she continues to push the boundaries of biopharmaceutical research.
Career Highlights
Throughout her career, So Yeon Park has worked with notable companies, including Prestige Biopharma IDC Co., Ltd. and Prestige Biopharma Pte. Ltd. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
So Yeon Park has collaborated with talented individuals such as Sang Seok Koh and Min Kyung Kang. These partnerships have enriched her research and expanded the impact of her innovations in the biopharmaceutical sector.
Conclusion
In summary, So Yeon Park is a trailblazer in the biopharmaceutical industry, with a focus on antibody development. Her innovative work and collaborations position her as a key figure in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile